))
#40 - Christine Senn, PhD, SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant
Manage episode 420960997 series 3478706
Kandungan disediakan oleh Slice of Healthcare LLC. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Slice of Healthcare LLC atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Join us on the latest episode! Our Guests: Christine Senn, PhD, the SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant.
What you'll get out of this episode:
- Rohit Nambisan discusses Lokavant's approach to leveraging AI in clinical trial feasibility.
- Christine Senn highlights the importance of thorough feasibility processes in rare disease trials.
- The need for diverse site participation and data inputs to improve trial accuracy and efficiency.
- The role of AI and technology in enhancing clinical trial processes.
To learn more about our guests and their companies:
Christine's LinkedIn https://www.linkedin.com/in/christinesenn/
Rohit's LinkedIn https://www.linkedin.com/in/rohitnambisan/
Advarra LinkedIn https://www.linkedin.com/company/advarra/
Lokavant LinkedIn https://www.linkedin.com/company/lokavant/
Advarra Website https://www.advarra.com/
Lokavant Website https://www.lokavant.com/en-us/
Our sponsor for this episode is:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
45 episod
Kongsi
